Lung cancer is the top killer cancer in the US. Monolayer cultures of lung cancer cells and their animal xenografts are major models for testing therapeutic modalities against lung cancer. Injection of suspended cancer cells into the lung is one of the most common approaches to build an orthotopic lung cancer model but carry several significant disadvantages, including the omission of a primary solid tumor and the artificial metastasis generated from the premature leakage of the injected cell suspension [1]. All such drawbacks could severely mislead the development of new therapies against lung cancer. Compared to cell monolayers or cell suspensions in culture, three-dimension (3D) cancer cell spheroids better mimic the tumor microenvironme...
The high attrition rates observed in cancer drug discovery (up to 95% of failure of drugs tested in ...
Despite many developments in recent years, non-small cell lung cancer (NSCLC) remains the leading ca...
<div><p>The prognosis of advanced non-small cell lung cancer (NSCLC) patients is poor. One of the re...
Lung cancer is the top killer cancer in the US. Monolayer cultures of lung cancer cells and their an...
Introduction: Lung cancer leads in mortality among all types of cancer in US and Non-small cell lung...
Lung cancer leads in mortality among all types of cancer in the US and Non-small cell lung cancer (N...
Lung cancer, which remains a major cause of mortality worldwide, is a histologically diverse conditi...
Lung cancer is the second most common cancer in both men and women around the world, and 85% of it i...
Lung cancer is the most lethal type of cancer in US. Mice injected with human cancer cells either un...
Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular model...
INTRODUCTION: We describe a novel 3D co-culture model using non-small cell lung cancer (NSCLC) cell ...
Cell cultures are traditionally studied as 2D monolayers with use of 3D culture systems gradually be...
Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular model...
The implementation of in vitro results to in vivo applications has limitations due to conventional t...
Three-dimensional (3 D) cell culture platforms are increasingly being used in cancer research and dr...
The high attrition rates observed in cancer drug discovery (up to 95% of failure of drugs tested in ...
Despite many developments in recent years, non-small cell lung cancer (NSCLC) remains the leading ca...
<div><p>The prognosis of advanced non-small cell lung cancer (NSCLC) patients is poor. One of the re...
Lung cancer is the top killer cancer in the US. Monolayer cultures of lung cancer cells and their an...
Introduction: Lung cancer leads in mortality among all types of cancer in US and Non-small cell lung...
Lung cancer leads in mortality among all types of cancer in the US and Non-small cell lung cancer (N...
Lung cancer, which remains a major cause of mortality worldwide, is a histologically diverse conditi...
Lung cancer is the second most common cancer in both men and women around the world, and 85% of it i...
Lung cancer is the most lethal type of cancer in US. Mice injected with human cancer cells either un...
Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular model...
INTRODUCTION: We describe a novel 3D co-culture model using non-small cell lung cancer (NSCLC) cell ...
Cell cultures are traditionally studied as 2D monolayers with use of 3D culture systems gradually be...
Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular model...
The implementation of in vitro results to in vivo applications has limitations due to conventional t...
Three-dimensional (3 D) cell culture platforms are increasingly being used in cancer research and dr...
The high attrition rates observed in cancer drug discovery (up to 95% of failure of drugs tested in ...
Despite many developments in recent years, non-small cell lung cancer (NSCLC) remains the leading ca...
<div><p>The prognosis of advanced non-small cell lung cancer (NSCLC) patients is poor. One of the re...